Toumaz Limited New £5m banking facility (7481C)
October 20 2015 - 2:00AM
UK Regulatory
TIDMTMZ
RNS Number : 7481C
Toumaz Limited
20 October 2015
20 October 2015
Toumaz Limited
New GBP5m banking facility
Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer
in low-power, wireless semiconductor technologies for healthcare
and digital audio, has signed a three year GBP5m term loan with
Clydesdale Bank Growth Finance. This is a senior term loan with
capital amortisation commencing from June 2016 with no dilution to
the equity.
Anthony Sethill, CEO of Toumaz Group, said:
"As we stated in our half years results in September 2015, we
expect to be cash generative from the middle of 2016. This loan
provides greater resilience to our existing reserves."
Enquiries
Toumaz Limited +44 (0) 207 391 0630
Anthony Sethill, Chief Executive Officer
Jonathan Apps, Chief Financial Officer
Peel Hunt LLP (Nominated Adviser and
Broker) +44 (0) 207 418 8900
Richard Kauffer/Euan Brown
Instinctif Partners +44 (0) 207 457 2020
Adrian Duffield/Lauren Foster
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor
and software technologies for digital audio and healthcare. The
company has two divisions, Frontier Silicon and Sensium Healthcare.
Frontier Silicon provides chips, modules and software for digital
radio and connected audio devices. Sensium Healthcare develops
wireless solutions for patient monitoring.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFFDIVLALIE
(END) Dow Jones Newswires
October 20, 2015 02:00 ET (06:00 GMT)
Nanoscience (LSE:NAN)
Historical Stock Chart
From Apr 2024 to May 2024
Nanoscience (LSE:NAN)
Historical Stock Chart
From May 2023 to May 2024
